30-December-2009
Multiple Sclerosis: A Breakthrough Is on the Way
Kerry Capell, BusinessWeek

21-December-2009
Novartis Shifts Focus to Rare Diseases
Jeanne Whalen, Wall Street Journal

9-December-2009
Small-Molecule Drugs for Targeting an Intracellular Signaling Pathway: Research and Development of New Oncology Drugs
Allan B. Haberman, Biopharmconsortium Blog

3-December-2009
Pharma Industry Prepares for End of 'Blockbuster Medicines'
EurActiv

3-November-2009
Novartis to Invest $1bn to Expand Chinese Research Laboratories
Geoff Dyer and Andrew Jack, Financial Times

3-November-2009
Pharma's Hiring! (In China)
James A. White, Wall Street Journal Blog

01-October-2009
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling.
Huang S.M.A.; Mishina Y.M.; Liu S.M.; Cheung A.; Stegmeier F.; Michaud G.A.; Charlat O.; Wiellette E.; Zhang Y.; Wiessner S.; Hild M.; Shi X.Y.; Wilson C.J.; Mickanin C.; Myer V.; Fazal A.; Tomlinson R.; Serluca F.; Shao W.L.; Cheng H.; Shultz M.; Rau C.; Schirle M.; Schlegl J.; Ghidelli S.; Fawell S.; Lu C.; Curtis D.; Kirschner M.W.; Lengauer C.; Finan P.M.; Tallarico J.A.; Bouwmeester T.; Porter J.A.; Bauer A.; and Cong F. Nature 461, 614-620.

17-September-2009
KDM1B is a histone H3K4 demethylase required to establish maternal genomic imprints.
Ciccone D.N.; Su H.; Hevi S.; Gay F.; Lei H.; Bajko J.; Xu G.L.; Li E.; and Chen T.P. Nature 461, 415-U115.

7-September-2009
Novartis Unveils New Lab Concept
Ann M. Thayer, Chemical & Engineering News

27-August 27-2009
Commentary: Mapping out Novartis's "pathways" approach to R&D
Asher Mullard, Scrip News

27-August 27-2009
Novartis Unveils New Lab Approach to Boost Research Capacity
Nicola O’Brien, PharmaFocus

25-August-2009
Novartis Unveils Futuristic Labs
Tim Studt, Laboratory Equipment ‎

24-Aug-2009
Novartis unveils Lab of Future concept to top European students at Biotechnology Leadership Camp (BioCamp)
Novartis press release

16-July-2009
All Together Now
The Economist

16-July-2009
Drug Sought for Diarrhea Common in Developing World
Jeanne Whalen, The Wall Street Journal

15-July-2009
OneWorld, Novartis sign diarrhea R&D deal
Ron Leuty, San Francisco Business Times

14-July-2009
Comprehensive Global Health Strategy
Richard Chin, The Huffington Post

14-July-2009
Novartis Taps CF Research In Hunt For Diarrhea Drugs
John Carroll, FierceBiotech

July-2009
Multi-Parameter Phenotypic Profiling: Using Cellular Effects To Characterize Small-Molecule Compounds
Y. Feng, T. Mitchison, A. Bender, D. Young and J. Tallarico, Nature Reviews Drug Discovery

19-June-2009
Novartis Scores Big Hit on Small Market With Gene-Based Medicine
Shirley Wang, Health Blog (Wall Street Journal)

19-June-2009
FDA Approves a Novel Novartis Drug
Jeanne Whalen, The Wall Street Journal

18-June-2009
The FDA O.K.'s Novartis' Ilaris
Kerry Capell, BusinessWeek

11-June-2009
Novartis: Radically Remaking Its Drug Business
Kerry Capell, BusinessWeek

7-June-2009
Research Reveals How Alzheimer's Spreads Within The Brain
Science Centric

22-May-2009
Big Drug Companies Hiring Steadily
Julie M. Donnelly,Boston Business Journal

8-May-2009
Novartis Will Expand In Cambridge; Drug Maker Signs Lease Deal, Plans To Build A New Facility
Casey Ross, The Boston Globe

13-April-2009
Mark T. Keating: Healing Hearts and Eyes
Adam Hadhazy, Scientific American

15-March-2009
Cellular Discovery May Lead To Targeted Treatment for Rare Form of Anemia
Science Daily

13-March-2009
Safety First! Careers in Drug Safety and Toxicology
Virginia Gewin, ScienceCareers.org

6-February-2009
Bidirectional transport of amino acids regulates mTOR and autophagy.
Nicklin P.; Bergman P.; Zhang B.; Triantafellow E.; Wang H.; Nyfeler B.; Yang H.; Hild M.; Kung C.; Wilson C.; Myer V.E.; MacKeigan J.P.; Porter J.A.; Wang Y.K.; Cantley L.C.; Finan P.M.; Murphy L.O. Cell 2009 Feb 6;136(3):521-34.

20-January-2009
High Throughput Screening Retools for the Future
Vicki Glaser, Bio-IT World

January-2009
The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity.
Pruenster M.; Mudde L.; Bombosi P.; Dimitrova S.; Zsak M.; Middleton J.; Richmond A.; Graham G.J.; Segerer S.; Nibbs R.J.B.; and Rot A. Nature Immunology 10, 101-108.

January-2009
The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation.
Wang J.; Hevi S.; Kurash J.K.; Lei H.; Gay F.; Bajko J.; Su H.; Sun W.T.; Chang H.; Xu G.L.; Gaudet F.; Li E.; and Chen T. Nature Genetics 41, 125-129.